Ocugen’s CSO to Highlight Gene Therapy Advances at Upcoming Conference
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has announced that its Chief Scientific Officer, Dr. Arun Upadhyay, will be a featured speaker at the 5th Annual Gene Therapy for Ophthalmic Disorders …
Ocugen’s CSO to Highlight Gene Therapy Advances at Upcoming Conference Read More